BioAge Labs (BIOA) Shares Outstanding (2023 - 2026)
BioAge Labs (BIOA) posted Shares Outstanding (Entity) of $44.4 million for Q1 2026, up 18.72% sequentially from $37.4 million in Q4 2025, and up 23.81% YoY from $35.9 million in Q1 2025.
BioAge Labs (BIOA) Shares Outstanding (2023 - 2026) Analysis & Trends
BioAge Labs has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $44.4 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 23.81% year-over-year to $44.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.4 million (up 23.81% YoY) and the FY2025 annual result came in at $37.4 million, up 248.55% from the prior year.
- Shares Outstanding (Entity) climbed to $44.4 million in Q1 2026 per BIOA's latest filing, from $37.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $44.4 million in Q1 2026 and troughed at $1.7 million in Q3 2023.
- A 4-year average of $19.1 million and a median of $10.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 2042.1% in 2025, then advanced 23.81% in 2026.
- Over 4 years, Shares Outstanding (Entity) stood at $1.7 million in 2023, then soared by 541.03% to $10.7 million in 2024, then soared by 248.55% to $37.4 million in 2025, then climbed by 18.72% to $44.4 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $44.4 million, $37.4 million, and $35.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | BioAge Labs | 439.65 Mn | 439.65 Mn | -14.23 Mn | 44.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.84 Mn |
| Mar 31, 2026 | 42.48 Mn |
| Dec 31, 2025 | 35.93 Mn |
| Sep 30, 2025 | 35.85 Mn |
| Jun 30, 2025 | 35.85 Mn |
| Mar 31, 2025 | 35.85 Mn |
| Dec 31, 2024 | 10.73 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 1.67 Mn |